Risk factors

Harmony Biosciences Holdings (HRMY) risk factors

Item 1A of every Harmony Biosciences Holdings, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open HRMY in Gloom →
Harmony Biosciences Holdings' chart, financials and news, free in your browser.Open HRMY in Gloom →
  • FY2025 10-K risk factors
    68 risks6 new6 dropped11 reworded

    Harmony Biosciences expanded risk disclosures around third-party payor price pressures, in-licensed intellectual property dependencies, and specific tax legislation changes.

    Filed Feb 24, 2026
  • FY2024 10-K risk factors
    68 risks

    Harmony Biosciences relies almost entirely on sales of WAKIX for narcolepsy and its licensing agreement with Bioprojet for pitolisant.

    Filed Feb 25, 2025